Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors

被引:10
|
作者
Ye, Xiaocong M. [1 ]
Konradi, Andrei W. [1 ]
Sun, Minghua [1 ]
Yuan, Shendong [1 ]
Aubele, Danielle L. [1 ]
Dappen, Michael [1 ]
Dressen, Darren [1 ]
Garofalo, Albert W. [1 ]
Jagodzinski, Jacek J. [1 ]
Latimer, Lee [1 ]
Probst, Gary D. [1 ]
Sham, Hing L. [1 ]
Wone, David [1 ]
Xu, Ying-zi [1 ]
Ness, Daniel [2 ]
Brigham, Elizabeth [2 ]
Kwong, Grace T. [2 ]
Willtis, Chris [2 ]
Tonn, George [3 ]
Goldbach, Erich [3 ]
Quinn, Kevin P. [3 ]
Zhang, Hongbin H. [3 ]
Sauer, John-Michael [3 ]
Bova, Michael [4 ]
Basi, Guriqbal S. [5 ]
机构
[1] Elan Pharmaceut, Dept Med Chem, San Francisco, CA 94080 USA
[2] Elan Pharmaceut, Dept Pharmacol, San Francisco, CA 94080 USA
[3] Elan Pharmaceut, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA
[4] Elan Pharmaceut, Dept Assay Dev, San Francisco, CA 94080 USA
[5] Elan Pharmaceut, Dept Biol, San Francisco, CA 94080 USA
关键词
Alzheimer's disease; Amyloid precursor protein; gamma-Secretase; gamma-Secretase inhibitor; Notch; ALZHEIMERS-DISEASE; GENES;
D O I
10.1016/j.bmcl.2012.12.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-activity relationship (SAR) of a novel, potent and metabolically stable series of benzo [3.2.1] bicyclic sulfonamide-pyrazoles as gamma-secretase inhibitors are described. Compounds that are efficacious in reducing the cortical A beta x-40 levels in FVB mice via oral dose, as well as those with high selectivity over Notch, are highlighted. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:996 / 1000
页数:5
相关论文
共 50 条
  • [41] Discovery, Development, and Cellular Delivery of Potent and Selective Bicyclic Peptide Inhibitors of Grb7 Cancer Target
    Watson, Gabrielle M.
    Kulkarni, Ketav
    Sang, Jianrong
    Ma, Xiuquan
    Gunzburg, Menachem J.
    Perlmutter, Patrick
    Wilce, Matthew C. J.
    Wilce, Jacqueline A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (22) : 9349 - 9359
  • [42] Novel bicyclic pyrazoles as potent ALK2 (R206H) inhibitors for the treatment of fibrodysplasia ossificans progressiva
    Yamamoto, Hirofumi
    Sakai, Naoki
    Ohte, Satoshi
    Sato, Tomohiro
    Sekimata, Katsuhiko
    Matsumoto, Takehisa
    Nakamura, Kana
    Watanabe, Hisami
    Mishima-Tsumagari, Chiemi
    Tanaka, Akiko
    Hashizume, Yoshinobu
    Honma, Teruki
    Katagiri, Takenobu
    Miyazono, Kohei
    Tomoda, Hiroshi
    Shirouzu, Mikako
    Koyama, Hiroo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 38
  • [43] Novel pyrrolyl 2-aminopyridines as potent and selective human β-secretase (BACE1) inhibitors
    Malamas, Michael S.
    Barnes, Keith
    Hui, Yu
    Johnson, Matthew
    Lovering, Frank
    Condon, Jeff
    Fobare, William
    Solvibile, William
    Turner, Jim
    Hu, Yun
    Manas, Eric S.
    Fan, Kristi
    Olland, Andrea
    Chopra, Rajiv
    Bard, Jonathan
    Pangalos, Menelas N.
    Reinhart, Peter
    Robichaud, Albert J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2068 - 2073
  • [44] Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing
    Li, Zhonghua
    Qin, Tingting
    Li, Zhongrui
    Zhao, Xuan
    Zhang, Xinhui
    Zhao, Taoqian
    Yang, Nian
    Miao, Jinxin
    Ma, Jinlian
    Zhang, Zhenqiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 225
  • [45] Discovery of aryl aminoquinazoline pyridones as potent selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit
    Hu, Essa
    Tasker, Andrew
    White, Ryan D.
    Kunz, Roxanne K.
    Human, Jason
    Chen, Ning
    Buerli, Roland
    Hungate, Randall
    Novak, Perry
    Itano, Andrea
    Zhang, Xuxia
    Yu, Violeta
    Nguyen, Yen
    Tudor, Yanyan
    Plant, Matthew
    Flynn, Shaun
    Xu, Yang
    Meagher, Kristin L.
    Whittington, Douglas A.
    Ng, Gordon Y.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (11) : 3065 - 3068
  • [46] Identification of the fused bicyclic 4-amino-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors
    Goto, Taiji
    Shiina, Akiko
    Yoshino, Toshiharu
    Mizukami, Kiyoshi
    Hirahara, Kazuki
    Suzuki, Osamu
    Sogawa, Yoshitaka
    Takahashi, Tomoko
    Mikkaichi, Tsuyoshi
    Nakao, Naoki
    Takahashi, Mizuki
    Hasegawa, Masashi
    Sasaki, Shigeki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3325 - 3328
  • [47] Discovery of novel cyclopentane carboxylic acids as potent and selective inhibitors of NaV1.7
    Sun, Shaoyi
    Chowdhury, Sultan
    Hemeon, Ivan
    Hasan, Abid
    Wilson, Michael S.
    Bergeron, Phillipe
    Jia, Qi
    Zenova, Alla Y.
    Grimwood, Mike E.
    Gong, Wei
    Decker, Shannon M.
    Bichler, Paul
    Andrez, Jean-Christophe
    Focken, Thilo
    Ngyuen, Theresa
    Zhu, Jiuxiang
    White, Andrew D.
    Bankar, Girish
    Howard, Sarah
    Chang, Elaine
    Khakh, Kuldip
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 116
  • [48] Discovery of novel pyrazinone derivatives as potent and selective caspase-3 inhibitors.
    Han, YX
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U81 - U81
  • [49] Discovery of substituted spiropiperidines as a novel chemotype of potent and selective GlyT1 inhibitors
    Pinard, E.
    Alberati, D.
    Borroni, E.
    Ceccarelli, S.
    Fischer, H.
    Hainzl, D.
    Jolidon, S.
    Moreau, J. L.
    Stalder, H.
    Thomas, A. W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [50] Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors
    Giroux, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U3315 - U3315